What does Eisai Co., Ltd. do?
Eisai Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals in Japan. The company operates through pharmaceuticals business and other business segments. It offers Lenvima, a multi-kinase inhibitor which is involved in tumor angiogenesis or tumor malignancy; LEQEMBI, a humanized IgG1…
What is Eisai Co., Ltd.'s P/E and P/B ratio?
Eisai Co., Ltd. has a P/E ratio of 37.0 and a P/B ratio of 1.59.
What is Eisai Co., Ltd.'s debt-to-equity ratio?
Eisai Co., Ltd. has a debt-to-equity ratio of 0.29.
What is Eisai Co., Ltd.'s Positivity rank?
Eisai Co., Ltd. is ranked #5,367 of 8,463 companies globally and #1,210 of 1,405 in Japan on PositoAI, with a Positivity Score of 20,116.
Does Eisai Co., Ltd. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Eisai Co., Ltd..
Where can I read the latest news about Eisai Co., Ltd.?
Recent headlines about Eisai Co., Ltd. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Eisai Co., Ltd. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Eisai Co., Ltd.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.